|
General Case Information
IMORTANT DATE CHANGE: The Court has re-scheduled the Settlement Fairness Hearing from October 6, 2008 to December 3, 2008 at 10:00 am.
IMORTANT NOTICE FOR CHIRON EMPLOYEE STOCK PURCHASE PLAN PARTICIPANTS: If you were a participant in Chiron's Employee Stock Purchase Plan, please review the Notice to CESPP Participants.
If you purchased or otherwise acquired shares of common stock of Chiron Corporation, now known as Novartis Vaccines and Diagnostics, Inc. ("Chiron"), during the period from July 23, 2003 through October 5, 2004, then you could get a payment from a class action settlement.
The settlement will provide a thirty million dollar ($30,000,000) plus interest settlement for the benefit of investors who purchased or otherwise acquired shares of Chiron common stock between July 23, 2003, and October 5, 2004, inclusive.
The settlement resolves a lawsuit over whether Chiron made allegedly false and misleading statements about the company's production of the Fluvirin flu vaccine, which allegedly maintained Chiron's stock price at an artificially inflated level throughout the Class Period.
Your legal rights are affected whether you act or do not act.
Please see the menu items on the left to download case related documents.
Contact us via email:
chironlitigation@gilardi.com
|
